Latest database descriptions

Describe the medical care of patients who have one or several secondary brain metastases to a primary breast cancer overexpressing HER2 and evaluate the cost of this from a health insurance standpoint

Develop a risk score of the appearance of venous thrombosis in patients with cancer, using clinical and biological parameters

The main objective of this study is to assess the economic and social consequences of oral cancer therapies in patients with advanced or metastatic breast cancer overexpressing Her2

• To assess the impact of low-to-moderate risk PCa on the subject’s QoL and
anxiety/depression at diagnosis and within the first year of treatment.
• To estimate health care consumption and utility values within the first year of
diagnosis of subjects with low-to-moderate risk PCa.
• To describe the profile and medical management of subjects with low-to-moderate
risk PCa from 5 countries in the European Union (EU), (France, Germany, Italy,
Spain and Sweden).